Skip to main content

Table 1 Global incidence, mortality, and DALYs of three urologic benign diseases from 1990 to 2019

From: Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019

  Urinary tract infections Urolithiasis Benign prostatic hyperplasia
Both Male Female Both Male Female Male
1990        
Incident case (× 105) 2522.46 (2233.14 to 2792.97) 488.47 (437.22 to 536.93) 2033.99 (1795.48 to 2259.36) 777.76 (622.39 to 951.27) 527.82 (421.54 to 644.73) 249.94 (199.72 to 305.78) 54.76 (42.00 to 71.16)
Deaths (× 103) 98.59 (89.03 to 106.32) 46.79 (39.61 to 52.73) 51.80 (46.42 to 56.17) 11.34 (7.28 to 13.78) 6.15 (3.08 to 8.03) 5.18 (3.51 to 6.12)  
DALYs (× 103) 3079.89 (2651.63 to 3381.62) 1471.72 (1224.73 to 1656.34) 1608.17 (1362.18 to 1807.36) 516.73 (374.13 to 635.72) 308.57 (207.19 to 392.88) 208.16 (152.47 to 249.07) 884.19 (526.63 to 1337.22)
ASIR 4989.87 (4434.39 to 5499.05) 1984.80 (1784.33 to 2175.01) 4989.87 (4434.39 to 5499.05) 1696.18 (1358.11 to 2078.11) 2353.15 (1878.96 to 2879.17) 1066.85 (851.17 to 1305.09) 285.46 (221.45 to 370.09)
ASMR 2.77 (2.51 to 3.02) 3.14 (2.67 to 3.59) 2.56 (2.31 to 2.77) 0.30 (0.20 to 0.37) 0.38 (0.2 to 0.5) 0.25 (0.17 to 0.29)  
ASDR 67.73 (59.96 to 73.45) 69.74 (59.16 to 78.72) 67.42 (58.34 to 74.51) 11.75 (8.57 to 14.39) 14.76 (9.92 to 18.82) 9.11 (6.73 to 10.91) 50.76 (30.39 to 76.18)
2019        
Incident case (× 105) 4046.12 (3594.25 to 4465.48) 871.90 (780.14 to 954.2) 3174.22 (2809.71 to 3512.61) 1155.52 (930.45 to 1401.8) 761.05 (610.28 to 921.68) 394.47 (316.44 to 479.04) 112.65 (87.90 to 144.55)
Deaths (× 103) 236.79 (198.43 to 259.03) 104.88 (82.41 to 117.43) 131.91 (111.61 to 145.72) 13.28 (10.62 to 16.27) 6.93 (4.5 to 9.14) 6.35 (5.17 to 8.29)  
DALYs (× 103) 5201.67 (4454.04 to 5704.84) 2407.94 (1949.07 to 2706.29) 2793.74 (2402.91 to 3098.75) 604.31 (477.35 to 745.19) 362.3 (274.44 to 454.56) 242.01 (193.91 to 299.06) 1861.78 (1127.72 to 2782.26)
ASIR 5075.89 (4516.65 to 5594.10) 2211.69 (1988.65 to 2420.05) 7945.83 (7045.47 to 8792.4) 1394.03 (1126.40 to 1688.16) 1856.87 (1495.27 to 2245.34) 947.22 (761.21 to 1148.43) 280.40 (219.62 to 360.32)
ASMR 3.13 (2.61 to 3.43) 3.27 (2.54 to 3.65) 3.05 (2.58 to 3.37) 0.17 (0.14 to 0.21) 0.20 (0.13 to 0.26) 0.15 (0.12 to 0.19)  
ASDR 66.17 (56.56 to 72.5) 65.64 (52.8 to 73.33) 67.21 (57.89 to 74.67) 7.35 (5.82 to 9.04) 9.10 (6.92 to 11.34) 5.72 (4.58 to 7.07) 48.90 (29.68 to 72.63)
1990–2019*        
Incident case (%) 60.40 78.50 56.06 48.57 44.19 57.82 105.70
Deaths (%) 140.18 124.17 154.64 17.12 12.62 22.46  
DALYs (%) 68.89 63.61 73.72 16.95 17.41 16.26 110.56
ASIR (EAPC, 95% CI) 0.08 (0.04 to 0.11) 0.39 (0.37 to 0.41) 0 (− 0.04 to 0.04)  − 0.83 (− 0.92 to − 0.74)  − 1.01 (− 1.09 to − 0.92)  − 0.47 (− 0.59 to − 0.36)  − 0.03 (− 0.05 to − 0.01)
ASMR (EAPC, 95% CI) 0.55 (0.47 to 0.62) 0.28 (0.23 to 0.34) 0.70 (0.62 to 0.78)  − 2.05 (− 2.24 to − 1.86)  − 2.32 (− 2.47 to − 2.18)  − 1.88 (− 2.15 to − 1.61)  
ASDR (EAPC, 95% CI)  − 0.08 (− 0.11 to − 0.04)  − 0.17 (− 0.21 to − 0.12)  − 0.04 (− 0.09 to 0.01)  − 1.77 (− 1.91 to − 1.64)  − 1.83 (− 1.94 to − 1.72)  − 1.76 (− 1.96 to − 1.56)  − 0.06 (− 0.08 to − 0.03)
  1. DALYs disability-adjusted life-years; ASIR age-standardized incidence rate; ASMR age-standardized mortality rate; ASDR age-standardized DALYs rate; EAPC estimated annual percentage change; CI confidence interval
  2. All data are reported as numbers or rates (per 100,000 persons with 95% uncertainty intervals)
  3. *Percentage represents the change in cases, EAPC represents the change in rates